Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles Why Gulf Markets Haven’t Reacted — Yet Hassan Jivraj Podcast: What Institutions Missed While Chasing Private Markets Julie Segal From Informing AI to Empowering Traders, Quality Data is Non-Negotiable Sponsored by CME Group